AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function

por Braun, Till, Klepzig, Hanna, Herling, Marco
Publicado 2023

Targeting cellular respiration as a therapeutic strategy in glioblastoma

por Shang, Enyuan, Nguyen, Trang Thi Thu, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2023

Addendum: Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

por Rao, Mayank, Bhattacharjee, Meenakshi, Shepard, Scott, Hsu, Sigmund
Publicado 2023

HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma

por Desai, Omkar, Wang, Rui
Publicado 2023

UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

por Husein, Melisa, Petignat, Patrick, Cohen, Marie
Publicado 2023

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

por Nazarian, Javad, Mason, Gary E., Ho, Cheng Ying, Panditharatna, Eshini, Kambhampati, Madhuri, Vezina, L. Gilbert, Packer, Roger J., Hwang, Eugene I.
Publicado 2023

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling

por Matissek, Stephan J., Karbalivand, Mona, Han, Weiguo, Boutilier, Ava, Yzar-Garcia, Estefania, Kehoe, Laura L., Gardner, Devin Storm, Hage, Adam, Fleck, Krista, Jeffers, Vicki, Rajsbaum, Ricardo, Elsawa, Sherine F.
Publicado 2023

Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy

por Goldstein, Michael
Publicado 2023

Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing

por Glenn, Sean T., Galbo, Phillip M., Luce, Jesse D., Miles, Kiersten Marie, Singh, Prashant K., Glynias, Manuel J., Morrison, Carl
Publicado 2023

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

por Escudero-Esparza, Astrid, Bartoschek, Michael, Gialeli, Chrysostomi, Okroj, Marcin, Owen, Sioned, Jirström, Karin, Orimo, Akira, Jiang, Wen G., Pietras, Kristian, Blom, Anna M.
Publicado 2023

GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide

por Ma, Jun, Wang, Ziyu, Chen, Clark C., Li, Ming
Publicado 2023

The molecular dialogue between the tumor cells and fibroblasts

por Butti, Ramesh, Kundu, Gopal C.
Publicado 2023

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis

por Parija, Monalisa, Adhya, Amit K., Mishra, Sandip K.
Publicado 2023

Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy

por Toll, Stephanie A., Tran, Hung N., Cotter, Jennifer, Judkins, Alexander R., Tamrazi, Benita, Biegel, Jaclyn A., Dhall, Girish, Robison, Nathan J., Waters, Kaaren, Patel, Palak, Cooper, Robert, Margol, Ashley S.
Publicado 2023

Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma

por Wang, Xiao, Liu, Shasha, Cao, Ling, Zhang, Tengfei, Yue, Dongli, Wang, Liping, Ping, Yu, He, Qianyi, Zhang, Chaoqi, Wang, Meng, Chen, Xinfeng, Gao, Qun, Wang, Dan, Zhang, Zhen, Wang, Fei, Yang, Li, Li, Jieyao, Huang, Lan, Zhang, Bin, Zhang, Yi
Publicado 2023

Role of creatine shuttle in colorectal cancer cells

por Kita, Mayu, Fujiwara-Tani, Rina, Kishi, Shingo, Mori, Shiori, Ohmori, Hitoshi, Nakashima, Chie, Goto, Kei, Sasaki, Takamitsu, Fujii, Kiyomu, Kawahara, Isao, Bhawal, Ujjal Kumar, Luo, Yi, Kuniyasu, Hiroki
Publicado 2023

Targeting the Src N-terminal regulatory element in cancer

por Mezquita, Betlem, Reyes-Farias, Marjorie, Pons, Miquel
Publicado 2023

Addendum: Laser speckle flowgraphy in juxtapapillary retinal capillary hemangioblastoma: a case report on natural course and therapeutic effect

por Mitamura, Mizuho, Kase, Satoru, Hirooka, Kiriko, Ishida, Susumu
Publicado 2023

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma

por Pietrobono, Silvia, Stecca, Barbara
Publicado 2023

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)

por Assi, Hazem I., Zerdan, Maroun Bou, Hodroj, Mohammad, Khoury, Makram, Naji, Nour Sabiha, Amhaz, Ghid, Zeidane, Reine Abou, El Karak, Fadi
Publicado 2023